18
May
2025
Why did Olanzapine Long-Acting Antipsychotics fail to continue?
Posted On May 18, 2025
By [email protected]
And has No Comment
Olanzapine pamoate (Zyprexa Relprevv) actually does exist as a long-acting injectable (LAI) antipsychotic, but it has had a more limited clinical adoption compared to other LAIs for several important reasons: This combination of safety concerns, logistical requirements, and market competition limited the widespread adoption of olanzapine […]
Read More